Hjem › Kolorektal kreft › Texas › Irving
Kliniske studier for Kolorektal kreft i Irving, TX
13 studier for Kolorektal kreft søker deltakere på steder i og rundt Irving (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors
RekruttererFase 1
- Exelixis Clinical Site #73, Irving
A Phase 1 Study of IM-1617 in Participants With Advanced Cancer
RekruttererFase 1
- NEXT Dallas, Irving
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
RekruttererFase 3
- US Oncology Investigational Products Center (IPC), Irving
- US Oncology Investigational Products Center, Irving
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
RekruttererFase 1/2
- NEXT Dallas, Irving
Study of RAS(ON) Inhibitors in Patients With Gastrointestinal Solid Tumors
RekruttererFase 1/2
- NEXT Oncology Dallas, Irving
A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors
RekruttererFase 1
- NEXT Dallas, Irving
Study of RAS(ON) Inhibitors in Combination With Ivonescimab in Patients With Solid Tumors
RekruttererFase 1/2
- NEXT Dallas, Irving
A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer
RekruttererFase 3
- US Oncology Investigational Product Center (IPC), Irving
- US Oncology Investigational Products Center (IPC), Irving
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
RekruttererFase 1
- NEXT Dallas, Irving
A Study of IDE034 in Adult Participants With Locally Advanced/Metastatic Solid Tumors Types
RekruttererFase 1
- NEXT Texas LLC - Dallas, Irving
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
RekruttererFase 1
- NEXT Oncology, Irving
A Study to Find a Suitable Dose of ASP5834 in Adults With Solid Tumors
RekruttererFase 1
- NEXT Oncology Dallas, Irving
Phase 1/2 Dose Finding, Safety and PK Study in Advanced Refractory Solid Tumors
RekruttererFase 1/2
- NEXT, Dallas, Irving
Kolorektal kreft-studier i andre byer
- Houston, TX102 studier
- New York City, NY77 studier
- Nashville, TN69 studier
- Boston, MA63 studier
- Los Angeles, CA59 studier
- Arlington, VA52 studier
- St. Louis, MO50 studier
- San Antonio, TX46 studier
- Philadelphia, PA44 studier
- Grand Rapids, MI40 studier
- Baldwin Park, CA38 studier
- Seattle, WA34 studier
Andre studier i Irving
- Ikke-småcellet lungekreft22 studier
- Kreft (alle typer)15 studier
- Metastatisk kreft11 studier
- Pankreaskreft7 studier
- Mavekreft7 studier
- Plateepitelcancer i hode og hals6 studier
- Brystkreft6 studier
- Småcellet lungekreft6 studier
- Lungekreft6 studier
- Eggstokkreft5 studier
- Endometriekreft4 studier
- Prostatakreft4 studier
Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.